Rationale: Cardiovascular physiology and pathophysiology vary dramatically over the course of the day. For example, myocardial infarction onset occurs with greater incidence during the early morning hours in humans. However, whether myocardial infarction tolerance exhibits a time-of-day dependence is unknown. Objective: To investigate whether time of day of an ischemic insult influences clinically relevant outcomes in mice. Methods and Results: Wild-type mice were subjected to ischemia/reperfusion (I/R) (45 minutes of ischemia followed by 1 day or 1 month of reperfusion) at distinct times of the day, using the closed-chest left anterior descending coronary artery occlusion model. Key Words: chronobiology Ⅲ ischemia/reperfusion Ⅲ myocardium N umerous aspects of cardiovascular physiology and pathophysiology demonstrate circadian rhythms. 1 In humans, heart rate, blood pressure, and cardiac output all increase in the early hours of the morning, as does the onset of adverse cardiac events, such as myocardial infarction. 2,3 These rhythms have been attributed primarily to time-of-day oscillations in neurohumoral influences, such as sympathetic or autonomic stimulation. 3, 4 Although extracardiac factors undoubtedly play critical roles in modulation of cardiovascular function/dysfunction, increasing evidence suggests that intrinsic factors, such as cellautonomous circadian clocks, likely contribute. 1 Circadian clocks are transcriptionally based molecular mechanisms, composed of positive-and negative-feedback loops, with a free-running period of Ϸ24 hours. 5 This mechanism allows the cell to anticipate alterations in environmental stimuli, through time-of-day-dependent modulation of cellular responsiveness to extrinsic factors. 5 Circadian clocks have been identified/characterized in multiple cardiovascular-relevant cell types, including cardiomyocytes, vascular smooth muscle cells, and endothelial cells. 6 -8 Ubiquitous genetic ablation of circadian clock function markedly influences multiple cardiovascular parameters, including heart rate and blood pressure. 9 We have recently used a CCM (cardiomyocyte-specific circadian clock mutant) mouse to reveal regulation of myocardial gene expression, ␤-adrenergic responsiveness, metabolism, heart rate, and cardiac power by this mechanism. 10, 11 Although circadian rhythms in myocardial infarction onset are well established, time-of-day oscillations in myocardial ischemia/reperfusion (I/R) tolerance have not been reported. Given that the cardiomyocyte circadian clock influences Original
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Methods
Wild-type (WT) and CCM mice were housed under controlled conditions in a 12-hour light/12-hour dark cycle (lights on at zeitgeber time [ZT]0, lights off at ZT12). The closed-chest left anterior descending coronary artery occlusion model of I/R was used (45 minutes ischemia); sham animals were subjected to identical surgical procedures, without coronary occlusion. 13 Following 1 day of reperfusion, TTC (2,3,5-triphenyltetrazolium chloride) staining was performed for measurement of infarct size; area at risk was determined by Evan's Blue staining. Echocardiographic (M-mode) assessment of cardiac function and histological analyses were performed following 1 month of reperfusion. Hearts from a separate set of mice not having undergone surgical intervention were isolated at distinct times of the day for gene and protein expression analyses.
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results
Consistent with loss of cardiomyocyte circadian clock function, diurnal oscillations in clock (bmal1) ( Figure 1A Following 1 day of reperfusion, WT hearts subjected to I/R at ZT12 exhibited an infarct size 3.5-fold greater than at ZT0 (PϽ0.05; Figure 2A ; Online Figure I , A). ZT12 infarct size was Ϸ21%, consistent with previous studies using the murine closedchest model. 13 Area at risk did not vary between groups (Online Figure I , B). Following identification of the peak and trough in infarct size (ie, ZT12 and ZT0, respectively), these 2 time points were used for long-term studies (ie, 1-month reperfusion).
To investigate whether observed diurnal variations in infarct size following 1 day reperfusion were associated with differences in long-term remodeling, hearts were studied following 1 month of reperfusion. As predicted, infarct volume and fibrosis increased in WT hearts following I/R at both ZT0 and ZT12 (relative to respective shams; Figure 2B and 2C; Online Figure I , A). However, these parameters were significantly greater when the ischemic insult was performed at ZT12 versus ZT0. Similarly, histological analysis revealed increased left ventricular end diastolic diameter (LVEDD) (a marker of adverse remodeling) only for WT hearts subjected to I/R at ZT12 ( Figure 3A) . LVEDD measures were reiterated by echocardiographic assessment of contractile function, whereas all I/R groups exhibited decreased ejection fraction and fractional shortening compared to their sham counterparts, WT hearts that underwent I/R at ZT12 exhibited the greatest depression of contractile function ( Figure 3B and 3C) .
Time-of-day-dependent oscillations in I/R tolerance in vivo could be secondary to extrinsic (eg, neurohumoral factors) and/or intrinsic (eg, circadian clocks) influences. 1 To investigate the role of the cardiomyocyte circadian clock, CCM mice were used. Consistent with temporal suspension of CCM hearts at the dark-to-light phase transition (ie, ZT0; Figure 1 and Bray et al 11 ), infarct size in CCM hearts (following 1 day reperfusion) was (Figure 2A) . Absence of time-of-day dependence in infarct size for CCM hearts was accompanied by attenuation/ abolition of diurnal variations in infarct volume, fibrosis, remodeling, and contractile dysfunction following 1 month of reperfusion (Figures 2 and 3) . Previously published studies in extracardiac tissues suggest that glycogen synthase kinase (GSK)-3␤, whose phosphorylation status oscillates over the course of the day in liver, is an integral circadian clock component. 14 Given the known central roles of Akt (v-akt murine thymoma viral oncogene) and GSK-3␤ in modulating I/R-induced myocardial damage, 15, 16 we investigated Akt and GSK-3␤ in WT and CCM hearts. Figure 4A and 4B shows that the phosphorylation of Akt and GSK-3␤ oscillate in WT hearts (eg, 1.8-fold oscillation for phosphorylated [P]-GSK-3␤, peaking at ZT0; PϽ0.05) and that phosphorylation is chronically elevated in CCM hearts. In contrast, total Akt and GSK-3␤ levels (as well as gsk-3␤ mRNA) are not different between groups (Online Figures II and III) . Importantly, negative correlations were observed for P-Akt and P-GSK3␤ levels with infarct size (Figure 4C and 4D) . In contrast, phosphorylation of p70S6K (downstream of Akt) did not correlate with infarct size (Online Figure IV) .
Non-standard Abbreviations and Acronyms

Discussion
The purpose of the present study was to determine whether I/R tolerance varies over the course of the day and, if so, to investigate the potential mediation by the cardiomyocyte circadian clock. Here, we expose dramatic time-of-daydependent variations in I/R tolerance, which are lost following genetic ablation of the cardiomyocyte circadian clock. Initial interrogation of possible molecular links between the cardiomyocyte circadian clock and myocardial I/R tolerance suggest that Akt and/or GSK-3␤ are potential mediators.
Diurnal variations in the onset of myocardial infarction are well established. 3 Humans are at greatest risk for myocardial infarction in the early hours of the morning, because of a combination of increased shear stress, sympathetic tone, and prothrombolytic factors at this time. 1, 3 However, whether the myocardium exhibits diurnal variations in I/R tolerance has not been reported. The brain exhibits a time-of-day dependence in ischemic tolerance. 17 Rats subjected to an ischemic episode at different times of the day exhibit greatest infarct sizes at ZT14, similar to our observations in the mouse heart (greatest infarct size at ZT12; Figure 2 ). ZT12 corresponds to the sleep-to-wake transition in the nocturnal rodent. As such, diurnal oscillations in the stimulus (ie, ischemia) and responsiveness (ie, infarct development) are in phase.
Circadian dyssynchronization is classically associated with cardiovascular morbidity and mortality. In humans, shift work significantly increases risk for cardiovascular disease development. 18 Similarly, subjecting cardiomyopathic hamsters to light/dark cycle manipulations augments early mortality. 19 Genetic modulation of circadian clock timing, resulting in subtle circadian dyssynchronization accelerates cardiac and renal disease, which is rescued by light/dark cyclemediated circadian resynchronization. 20 In the present study, genetic ablation of the cardiomyocyte circadian clock results in cardioprotection. The apparent discrepancy is likely attributable to the observation that CCM hearts are temporally suspended at the wake-to-sleep (dark-to-light) phase transition (Figure 1) , 11 a time of the day at which WT hearts exhibit greatest I/R tolerance. CCM mice are therefore distinct from models wherein circadian dyssynchronization occurs following classic shift work paradigms.
In summary, the present study reveals profound time-ofday dependence in myocardial I/R tolerance, mediated by the cardiomyocyte circadian clock. Rhythms in I/R-induced myocardial damage/dysfunction are in phase with established rhythms of myocardial infarction onset. The implications of these observations range from bench (eg, time of day consideration for experiments) to bedside (eg, chronotherapy).
